Literature DB >> 16364758

Bell-shaped nuclei dividing by symmetrical and asymmetrical nuclear fission have qualities of stem cells in human colonic embryogenesis and carcinogenesis.

E V Gostjeva1, L Zukerberg, D Chung, W G Thilly.   

Abstract

Large cell nuclei with at least eight distinct morphologies have been discovered throughout the fetal gut (5-7 weeks), colonic adenomas, and adenocarcinomas, five of which are not present in the normal adult colon. The most remarkable nuclear forms are hollow bells, approximately 10-15 microns in height and about 7-10 microns in bell mouth diameter. When encased in tubular syncytia, these bell-shaped structures divide symmetrically by an amitotic nuclear fission process resembling the separation of two paper cups. Seven other nuclear morphotypes emerge from the bell-shaped nuclei within the syncytia by asymmetrical amitotic nuclear fission. Cells containing these differentiated nuclear forms subsequently divide extra-syncytially by mitoses that form clonal populations of cells with identical nuclear morphotypes in embryos, adenomas, adenocarcinomas, and metastases. Cells with bell-shaped nuclei thus appear to be responsible for both net growth and differentiation in the embryonic gut, adenomas, and adenocarcinomas, and fulfill the requirements for post-embryonic stem cells in colon organogenesis and carcinogenesis.

Entities:  

Mesh:

Year:  2006        PMID: 16364758     DOI: 10.1016/j.cancergencyto.2005.05.005

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  9 in total

1.  Metakaryotic stem cell lineages in organogenesis of humans and other metazoans.

Authors:  Elena V Gostjeva; Vera Koledova; Aoy Tomita-Mitchell; Michael Mitchell; Mary A Goetsch; Susannah Varmuza; Janna N Fomina; Firouz Darroudi; William G Thilly
Journal:  Organogenesis       Date:  2009-10       Impact factor: 2.500

Review 2.  Arterial calcification: Finger-pointing at resident and circulating stem cells.

Authors:  Francesco Vasuri; Silvia Fittipaldi; Gianandrea Pasquinelli
Journal:  World J Stem Cells       Date:  2014-11-26       Impact factor: 5.326

3.  Human fetal/tumor metakaryotic stem cells: pangenomic homologous pairing and telomeric end-joining of chromatids.

Authors:  Amanda N Gruhl; Elena V Gostjeva; William G Thilly; Janna N Fomina; Firouz Darroudi
Journal:  Cancer Genet Cytogenet       Date:  2010-12

Review 4.  Anti-cancer therapies that utilize cell penetrating peptides.

Authors:  Benjamin G Bitler; Joyce A Schroeder
Journal:  Recent Pat Anticancer Drug Discov       Date:  2010-06       Impact factor: 4.169

Review 5.  Mutator/Hypermutable fetal/juvenile metakaryotic stem cells and human colorectal carcinogenesis.

Authors:  Lohith G Kini; Pablo Herrero-Jimenez; Tushar Kamath; Jayodita Sanghvi; Efren Gutierrez; David Hensle; John Kogel; Rebecca Kusko; Karl Rexer; Ray Kurzweil; Paulo Refinetti; Stephan Morgenthaler; Vera V Koledova; Elena V Gostjeva; William G Thilly
Journal:  Front Oncol       Date:  2013-10-29       Impact factor: 6.244

6.  Metakaryotic stem cell nuclei use pangenomic dsRNA/DNA intermediates in genome replication and segregation.

Authors:  William G Thilly; Elena V Gostjeva; Vera V Koledova; Lawrence R Zukerberg; Daniel Chung; Janna N Fomina; Firouz Darroudi; B David Stollar
Journal:  Organogenesis       Date:  2014-01-13       Impact factor: 2.500

7.  The study of calcified atherosclerotic arteries: an alternative to evaluate the composition of a problematic tissue reveals new insight including metakaryotic cells.

Authors:  Silvia Fittipaldi; Francesco Vasuri; Alessio Degiovanni; Rodolfo Pini; Mauro Gargiulo; Andrea Stella; Gianandrea Pasquinelli; William G Thilly; Elena V Gostjeva
Journal:  BMC Clin Pathol       Date:  2016-07-29

Review 8.  Stem cells and colorectal carcinogenesis.

Authors:  M Stoian; V Stoica; G Radulian
Journal:  J Med Life       Date:  2016 Jan-Mar

Review 9.  Nuclear morphologies: their diversity and functional relevance.

Authors:  Benjamin M Skinner; Emma E P Johnson
Journal:  Chromosoma       Date:  2016-09-08       Impact factor: 4.316

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.